EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

The Socioeconomic Impact of Long-Acting Injectable Buprenorphine

Samuel E Rasche, George O W Batchelor, Catharine Montgomery, Harry R Sumnall iD, Daniel Mogford iD

ClinicoEconomics and Outcomes Research · 2026-05 · Volume 18 · 1-12

DOI: 10.2147/ceor.s590462 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ClinicoEconomics and Outcomes Research, 2026-05. Verfasst von Samuel E Rasche und 4 weiteren Autor:innen. Beteiligte Einrichtung: Edge Health, London, UK. Die Arbeit nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

disorders due to use of opioidslong-acting injectable buprenorphinemethadoneopioidssublingual buprenorphine

Autor:innen und Institutionen

  • Edge Health, London, UK.
  • School of Psychology, Liverpool John Moores University, Liverpool, UK.
  • Camurus Ltd., Cambridge, UK.

ORCID-Profile: Harry R Sumnall, Daniel Mogford

Zitieren

APA

Rasche, S. E., Batchelor, G. O. W., Montgomery, C., Sumnall, H. R., & Mogford, D. (2026). The Socioeconomic Impact of Long-Acting Injectable Buprenorphine. ClinicoEconomics and Outcomes Research, Volume 18, 1-12. https://doi.org/10.2147/ceor.s590462

Vancouver

Rasche SE, Batchelor GOW, Montgomery C, Sumnall HR, Mogford D. The Socioeconomic Impact of Long-Acting Injectable Buprenorphine. ClinicoEconomics and Outcomes Research. 2026;Volume 18:1-12. doi:10.2147/ceor.s590462

BibTeX
@article{Rasche2026,
  author = {Rasche, Samuel E and Batchelor, George O W and Montgomery, Catharine and Sumnall, Harry R and Mogford, Daniel},
  title = {The Socioeconomic Impact of Long-Acting Injectable Buprenorphine},
  journal = {ClinicoEconomics and Outcomes Research},
  year = {2026},
  volume = {Volume 18},
  pages = {1--12},
  doi = {10.2147/ceor.s590462}
}
Kostenlos starten →